These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 10611186

  • 1. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.
    Beckers NG, Laven JS, Eijkemans MJ, Fauser BC.
    Hum Reprod; 2000 Jan; 15(1):43-9. PubMed ID: 10611186
    [Abstract] [Full Text] [Related]

  • 2. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D, Pellicer A, Guanes PP, Remohí J, Simón C.
    Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
    [Abstract] [Full Text] [Related]

  • 3. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A, Raziel A, Strassburger D, Soffer Y, Bukovsky I, Ron-El R.
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
    Peñarrubia J, Balasch J, Fábregues F, Creus M, Casamitjana R, Ballescá JL, Puerto B, Vanrell JA.
    Hum Reprod; 1998 Dec; 13(12):3315-8. PubMed ID: 9886506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone.
    Herman A, Ron-El R, Golan A, Nachum H, Soffer Y, Caspi E.
    Hum Reprod; 1992 Apr; 7(4):465-8. PubMed ID: 1325988
    [Abstract] [Full Text] [Related]

  • 11. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome.
    Shalev E, Geslevich Y, Ben-Ami M.
    Hum Reprod; 1994 Mar; 9(3):417-9. PubMed ID: 8006128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women.
    Smitz J, Van Den Abbeel E, Bollen N, Camus M, Devroey P, Tournaye H, Van Steirteghem AC.
    Hum Reprod; 1992 Sep; 7(8):1098-102. PubMed ID: 1400933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women.
    Beckers NG, Platteau P, Eijkemans MJ, Macklon NS, de Jong FH, Devroey P, Fauser BC.
    Eur J Endocrinol; 2006 Aug; 155(2):355-63. PubMed ID: 16868151
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of ovarian stimulation on corpus luteum function and embryonic implantation.
    Tavaniotou A, Albano C, Smitz J, Devroey P.
    J Reprod Immunol; 2002 Aug; 55(1-2):123-30. PubMed ID: 12062827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.